Abstract
This chapter describes the clinical evaluation process of patients with retinitis pigmentosa (RP). The clinical evaluation consists of a complete history and ophthalmic examination. Here, we outline the aspects of the history and ophthalmic exam that are most important for the evaluation of RP patients. In addition, the expected findings of RP patients and the etiology of these findings are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pagon RA (1988) Retinitis pigmentosa. Surv Ophthalmol 33(3):137–177
Zeavin BH, Wald G (1956) Rod and cone vision in retinitis pigmentosa. Am J Ophthalmol 42(4):253–269
Berson EL, Rosner B, Simonoff E (1980) Risk factors for genetic typing and detection in retinitis pigmentosa. Am J Ophthalmol 89(6):763–775
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368(9549):1795–1809
Hajali M, Fishman GA, Anderson RJ (2008) The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol 92(8):1065–1068
Fujiwara K, Ikeda Y, Murakami Y, Nakatake S, Tachibana T, Yoshida N et al (2016) Association between aqueous flare and epiretinal membrane in retinitis pigmentosa. Invest Ophthalmol Vis Sci 57(10):4282–4286
Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL (2005) The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 46(9):3349–3354
Fishman GA (1978) Retinitis pigmentosa. Visual loss. Arch Ophthalmol 96(7):1185–1188
Fishman GA, Farber MD, Derlacki DJ (1988) X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol 106(3):369–375
Pierrache LH, Hartel BP, van Wijk E, Meester-Smoor MA, Cremers FP, de Baere E et al (2016) Visual prognosis in USH2A-associated retinitis pigmentosa is worse for patients with usher syndrome type IIa than for those with nonsyndromic retinitis pigmentosa. Ophthalmology 123(5):1151–1160
Azoulay L, Chaumet-Riffaud P, Jaron S, Roux C, Sancho S, Berdugo N et al (2015) Threshold levels of visual field and acuity loss related to significant decreases in the quality of life and emotional states of patients with retinitis pigmentosa. Ophthalmic Res 54(2):78–84
Grunwald JE, Maguire AM, Dupont J (1996) Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol 122(4):502–508
Badeeb O, Trope G, Musarella M (1993) Primary angle closure glaucoma and retinitis pigmentosa. Acta Ophthalmol 71(6):727–732
Ziaei M, Khalili A, Wormald R (2013) Retinal dystrophy and primary angle-closure glaucoma. Int Ophthalmol 33(6):737–739
Xu J, Ouyang Z, Yang Y, Cai X, Wang Z, Lin M et al (2017) Ocular biometry in primary angle-closure glaucoma associated with retinitis pigmentosa. J Ophthalmol 2017:5
Küchle M, Nguyen NX, Martus P, Freissler K, Schalnus R (1998) Aqueous flare in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 236(6):426–433
Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T et al (2013) Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120(1):100–105
Heckenlively J (1982) The frequency of posterior subcapsular cataract in the hereditary retinal degenerations. Am J Ophthalmol 93(6):733–738
Fishman GA, Anderson RJ, Lourenco P (1985) Prevalence of posterior subcapsular lens opacities in patients with retinitis pigmentosa. Br J Ophthalmol 69(4):263–266
Gwon A, Mantras C, Gruber L, Cunanan C (1993) Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis. Invest Ophthalmol Vis Sci 34(13):3483–3488
Pruett RC (1975) Retinitis pigmentosa: a biomicroscopical study of vitreous abnormalities. JAMA Ophthalmol 93(8):603–608
Schepens CL, Avila MP, Jalkh AE, Trempe CL (1984) Role of the vitreous in cystoid macular edema. Surv Ophthalmol 28(Suppl):499–504
Newsome DA, Michels RG (1988) Detection of lymphocytes in the vitreous gel of patients with retinitis pigmentosa. Am J Ophthalmol 105(6):596–602
Fishman GA, Cunha-Vaz J, Salzano T (1981) Vitreous fluorophotometry in patients with retinitis pigmentosa. Arch Ophthalmol 99(7):1202–1207
Yu DY, Cringle SJ (2005) Retinal degeneration and local oxygen metabolism. Exp Eye Res 80(6):745–751
Ma Y, Kawasaki R, Dobson LP, Ruddle JB, Kearns LS, Wong TY, Mackey DA (2012) Quantitative analysis of retinal vessel attenuation in eyes with retinitis pigmentosa. Invest Ophthalmol Vis Sci 53(7):4306–4314
Milam AH, Li ZY, Fariss RN (1998) Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 17(2):175–205
Bunt-Milam AH, Kalina RE, Pagon RA (1983) Clinical-ultrastructural study of a retinal dystrophy. Invest Ophthalmol Vis Sci 24(4):458–469
Merin S, Auerbach E (1976) Retinitis pigmentosa. Surv Ophthalmol 20(5):303–346
Szamier RB (1981) Ultrastructure of the preretinal membrane in retinitis pigmentosa. Invest Ophthalmol Vis Sci 21(2):227–236
Sastry SM, Li ZY, Milam AH (1996) Epiretinal membranes in retinitis pigmentosa. Invest Ophthalmol Vis Sci 37(3):4789
Al Rashaed S, Khan AO, Nowilaty SR, Edward DP, Kozak I (2016) Spectral-domain optical coherence tomography reveals prelaminar membranes in optic nerve head pallor in eyes with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 254(1):77–81
Sacks JG, O’Grady RB, Choromokos E, Leestma J (1977) The pathogenesis of optic nerve drusen. Arch Ophthalmol 95:425–428
Puck A, Tso MOM, Fishman GA (1985) Drusenof the optic nerve associated with retinitis pigmentosa. Arch Ophthalmol 103:231–234
Newsome DA (1986) Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol 101(3):354–360
Bakthavatchalam M, Lai FHP, Rong SS, Ng DS, Brelen ME (2018) Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review. Surv Ophthalmol 63(3):329–339
Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. JAMA Ophthalmol 106(9):1190–1195
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hirji, S.H. (2023). Clinical Evaluation of Patients with Retinitis Pigmentosa. In: Tsang, S.H., Quinn, P.M. (eds) Retinitis Pigmentosa. Methods in Molecular Biology, vol 2560. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2651-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2651-1_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2650-4
Online ISBN: 978-1-0716-2651-1
eBook Packages: Springer Protocols